$RMD Q1 '27 Earnings Results & Recap
• Reported GAAP EPS of $2.91 up 14.12% YoY
• Reported revenue of $1.41B up 5.93% YoY
• Resmed maintained FY 2027 guidance, unchanged from August 6, 2026: core constant currency revenue growth of 57%, reported revenue of $5.75B, and non-GAAP diluted EPS of $12.00$12.25.